​

Generate Biomedicines Ownership | Who Owns Generate Biomedicines?


OverviewRevenueFinancialsChart

Generate Biomedicines Ownership Summary


Generate Biomedicines is owned by 78.19% institutional investors, 14.05% insiders, and 7.76% retail investors. Flagship pioneering is the largest institutional shareholder, holding 48.89% of GENB shares. American Funds SMALLCAP World A is the top mutual fund, with 2.92% of its assets in Generate Biomedicines shares.

GENB Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockGenerate Biomedicines78.19%14.05%7.76%
SectorFinancial Services Stocks 493.55%13.79%-407.34%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Flagship pioneering62.67M48.89%$783.41M
Fmr7.19M5.60%$107.94M
Capital world investors4.20M3.28%$63.11M
Braidwell lp3.59M2.80%$44.91M
Jpmorgan chase2.65M2.07%$40.94M
Vanguard capital management2.24M1.74%$33.58M
Price t rowe associates inc /md/2.11M1.65%$26.37M
Ark investment management1.96M1.53%$29.51M
Arch venture management1.94M1.52%$24.31M
Blackrock funding, inc. /de1.83M1.43%$27.49M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Flagship pioneering62.67M67.44%$783.41M
Harbourvest partners1.72M16.69%$25.87M
Arch venture management1.94M3.59%$24.31M
Davern capital partners, lp824.68K2.41%$12.39M
Braidwell lp3.59M1.50%$44.91M
Prosight management, lp144.76K0.42%$2.17M
Sphera funds management185.00K0.37%$2.31M
Siren736.10K0.26%$11.06M
Ark investment management1.96M0.17%$29.51M
Neo ivy capital management33.88K0.11%$508.95K

Top Buyers

HolderShares% AssetsChange
Flagship pioneering62.67M67.44%62.67M
Braidwell lp3.59M1.50%3.59M
Price t rowe associates inc /md/2.11M0.00%2.11M
Fmr7.19M0.00%1.96M
Arch venture management1.94M3.59%1.94M

Top Sellers

HolderShares% AssetsChange
Harvard management---1.11M
Alyeska investment group---500.00K
Exoduspoint capital management, lp---311.99K
Affinity asset advisors100.00K0.06%-300.00K
Sixth street partners management company---224.60K

New Positions

HolderShares% AssetsChangeValue
Flagship pioneering62.67M67.44%62.67M$783.41M
Braidwell lp3.59M1.50%3.59M$44.91M
Price t rowe associates inc /md/2.11M0.00%2.11M$26.37M
Arch venture management1.94M3.59%1.94M$24.31M
Baker bros. advisors lp1.42M0.10%1.42M$17.80M

Sold Out

HolderChange
Caitong asset management-1.00
Hollencrest capital management-5.00
Benson wealth management-363.00
Fny investment advisers-3.00K
Strs ohio-4.80K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20268851.72%100,275,8338.03%781.49%6817.24%10-
Mar 31, 202628-10,533,115-8-28---

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A3.75M2.92%-
Fidelity Growth Company Fund2.19M1.70%1.34M
Vanguard MStar Total Stk Mkt Idx Invest1.89M1.47%1.07M
ARK Genomic Revolution ETF1.64M1.28%9.46K
T. Rowe Price Health Sciences1.02M0.80%-765.57K
Fidelity Growth Compy Commingled Pl S989.76K0.77%141.50K
ARK Genomic Revolution833.27K0.65%358.32K
Vanguard Total Stock Mkt Idx Inv816.88K0.64%720.00K
Vanguard Morn Total Stk Mkt Idx Investor816.88K0.64%720.00K
Fidelity Growth Company K6695.89K0.54%459.85K

Recent Insider Transactions


DateNameRoleActivityValue
Oct 29, 2026ARNOLD FRANCES-Sell$184.73K
Sep 01, 2026ARNOLD FRANCES-Sell$16.00K

GENB Ownership FAQ


Who Owns Generate Biomedicines?

Generate Biomedicines shareholders are primarily institutional investors at 78.19%, followed by 14.05% insiders and 7.76% retail investors. The average institutional ownership in Generate Biomedicines's industry, Biotech Stocks , is 385.89%, which Generate Biomedicines falls below.

Who owns the most shares of Generate Biomedicines?

Generate Biomedicines’s largest shareholders are Flagship pioneering (62.67M shares, 48.89%), Fmr (7.19M shares, 5.60%), and Capital world investors (4.2M shares, 3.28%). Together, they hold 57.77% of Generate Biomedicines’s total shares outstanding.

Does Blackrock own Generate Biomedicines?

BlackRock is not among the top 10 institutional shareholders of Generate Biomedicines.

Who is Generate Biomedicines’s biggest shareholder by percentage of total assets invested?

Flagship pioneering is Generate Biomedicines’s biggest shareholder by percentage of total assets invested, with 67.44% of its assets in 62.67M Generate Biomedicines shares, valued at 783.41M$.

Who is the top mutual fund holder of Generate Biomedicines shares?

American Funds SMALLCAP World A is the top mutual fund holder of Generate Biomedicines shares, with 2.92% of its total shares outstanding invested in 3.75M Generate Biomedicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools